View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A multicenter study of apheresis collection of peripheral blood mononuclear cells (PBMC) in patients with CD19 expressing malignancies who could be eligible for a CTL019 clinical research trial.
  • Protocol ID
    CCtl019B2206
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Royal Children's Hospital Melbourne
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Not applicable
  • Study type
    Treatment
  • Diagnosis stage
    Relapse/refractory
  • Study open date
    17/09/2015
  • Study close date
    N/A
  • Study chair
  • Sponsor
    Novartis
Back to search results